• Brand
  • CGE Healthcare participates in the CPHI and attracts broad attention with its innovative strength


    On June 26-28, 2014, the 14th China CPHI (Convention on Pharmaceutical Ingredients China) was held in Shanghai New International Expo Center. CGE Healthcare and its subsidiaries Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Baoding Jiufu Biochemical Co., Ltd. and Jiangsu Grand Xinyi Pharmaceutical Co., Ltd. participated in the exhibition. 

    Seeking business opportunities at the worldwide CPHI China event

    After more than two decades of development, CPHI has established enormous worldwide influence and now plays an irreplaceable role in the global pharmaceutical raw material industry. It provides professionals with comprehensive and integrated solutions for pharmaceutical raw materials, contract formations, biopharmaceuticals, pharmaceutical machineries, packing materials and laboratory appliances. 2014 CPHI attracted nearly 3,000 participating companies, including overseas companies from more than 20 countries and regions. The event attracted numerous renowned pharmaceutical companies from China and abroad. It not only expanded the sourcing channels for purchasing managers, but also created a one-stop trading platform for pharmaceutical industry players to gather market information and carry out in-depth communications.

    In the dynamic global medicine market and with domestic market getting increasingly strong, CPHI provides CGE Healthcare with excellent opportunities to find new partners and suppliers, to maintain good relationships with current suppliers, and to stay on top of industry trends.

    Innovative products attracted attentions 

    Baoding Jiufu Biochemical Co., Ltd., the largest producer of key intermediates for steroid drugs in China, brought to the expo key products including androstenedione and its derivatives, diethylaminoethanethiol, high-end steroidal compounds and amino acid intermediates

    Sichuan Yuanda Shuyang Pharmaceutical is a leading blood product provider in China. The company is among the first blood product manufacturers that were simultaneously granted both GMP and ISO Quality Certificates, and has a history of making great contributions to major emergencies such as the prevention and treatment of SARS and earthquake relief. At the exhibition, its main products human serum albumin, intravenous human immunoglobulin, human immunoglobulin and HBV human immunoglobulin etc. attracted many overseas buyers.

    CGE Healthcare made a grand show

    CGE Healthcare made a grand show at the CPHI.  The show attracted many major customers for business talks, keys products introductions, and for major concerns in sales policies, corporate development,etc. to get addressed. Yue Jin, President of CGE Healthcare, had discussions with various customers and with managements of member companies about market opportunities and trend. Frank and cordial dialogues with customers created many opportunities for future business growth.

    At the CPHI exhibition, CGE Healthcare bursted into spotlight. Its booth attracted large amount of visitors.  Combinations of CGE healthcare overall strength, the great efforts made in booth and exhibition contents, and member companies’ creative marketing and sales techniques all contributed to CGE’s grand show. 

    The participation at CPHI Shanghai Expo is a grand show of CGE Healthcare brand in the global pharmaceutical market. The expo not only helped it better understand the market development trend and expand business cooperation, but also helped further enhance CGE Healthcare brand, and make its key products better known in industry.

     11111 (1).jpg

    22222 (1).jpg